125 related articles for article (PubMed ID: 9057674)
1. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Blood; 1997 Mar; 89(5):1838-9. PubMed ID: 9057674
[No Abstract] [Full Text] [Related]
2. Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
Robak T; Jamroziak K; Gora-Tybor J; Blonski JZ; Kasznicki M; Dwilewicz-Trojaczek J; Wiater E; Zdunczyk A; Dybowicz J; Dmoszynska A; Wojtaszko M; Zdziarska B; Calbecka M; Kostyra A; Hellmann A; Lewandowski K; Stella-Holowiecka B; Sulek K; Gawronski K; Skotnicki AB; Nowak W; Zawilska K; Molendowicz-Portala L; Kloczko J; Sokolowski J; Warzocha K; Seferynska I; Ceglarek B; Konopka L
Blood; 2007 May; 109(9):3672-5. PubMed ID: 17209059
[TBL] [Abstract][Full Text] [Related]
3. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).
Zenhäusern R; Schmitz SF; Solenthaler M; Heim D; Meyer-Monard S; Hess U; Leoncini L; Bargetzi M; Rufener B; Tobler A
Leuk Lymphoma; 2009 Sep; 50(9):1501-11. PubMed ID: 19672771
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y
Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268
[TBL] [Abstract][Full Text] [Related]
7. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
Beksaç M; Arat M; Idilman R
Cancer; 1999 Jan; 85(1):242-3. PubMed ID: 9921999
[No Abstract] [Full Text] [Related]
8. Purpuric rash following treatment with 2-chlorodeoxyadenosine.
Hendrick A
Clin Lab Haematol; 2001 Feb; 23(1):67-8. PubMed ID: 11422236
[No Abstract] [Full Text] [Related]
9. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
Dinçol G; Kahraman R
Am J Hematol; 2006 May; 81(5):387. PubMed ID: 16628737
[No Abstract] [Full Text] [Related]
10. Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.
Ravandi F; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Koller C; Challagundla P; York S; Brandt M; Luthra R; Burger J; Thomas D; Keating M; Kantarjian H
Blood; 2011 Oct; 118(14):3818-23. PubMed ID: 21821712
[TBL] [Abstract][Full Text] [Related]
11. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
Koczwara B; Spangenthal E; Bernstein SH
Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907
[TBL] [Abstract][Full Text] [Related]
12. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia.
Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T
Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414
[No Abstract] [Full Text] [Related]
13. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
Huynh E; Sigal D; Saven A
Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
[TBL] [Abstract][Full Text] [Related]
14. Immediate or delayed therapy with 2-CdA for hairy cell leukemia in Jehova's Witness?
Juliusson G
Am J Hematol; 1996 Sep; 53(1):49. PubMed ID: 8813099
[No Abstract] [Full Text] [Related]
15. Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia.
Damasio EE; Resegotti L; Masoudi B; Bruni R; Cerri R; Isaza A; Clavio M; Risso M; Rossi E; Spriano M; Truini M
Recenti Prog Med; 1998 Feb; 89(2):68-73. PubMed ID: 9558908
[TBL] [Abstract][Full Text] [Related]
16. Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution.
Grey MR; Flanagan NG; Kelsey PR
Clin Lab Haematol; 2000 Apr; 22(2):111-3. PubMed ID: 10792402
[TBL] [Abstract][Full Text] [Related]
17. [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine].
Kokunai A; Azusawa H; Murota H; Ohhata C; Katayama I; Murata S; Tadokoro S
Arerugi; 2006 Jun; 55(6):662-6. PubMed ID: 16883103
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia.
Ikpeazu EV; Kaplon MK
Eur J Haematol; 1998 Oct; 61(4):286-7. PubMed ID: 9820640
[No Abstract] [Full Text] [Related]
19. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
von Rohr A; Schmitz SF; Tichelli A; Hess U; Piguet D; Wernli M; Frickhofen N; Konwalinka G; Zulian G; Ghielmini M; Rufener B; Racine C; Fey MF; Cerny T; Betticher D; Tobler A;
Ann Oncol; 2002 Oct; 13(10):1641-9. PubMed ID: 12377655
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestation of hairy cell leukemia with dramatic response to 2-chloro-deoxy-adenosine.
Robinson A; Eting E; Zeidman A; Djaldetti M; Mittelman M; Savir H
Am J Ophthalmol; 1996 Jan; 121(1):97-9. PubMed ID: 8554090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
